# data[].attributes.body
Parasitological diagnosis

Light microscopy

Immunochromatographic rapid diagnostic tests (RDT's)

# data[].attributes.body
http://www.who.int/news-room/fact-sheets/detail/malaria
http://apps.who.int/iris/bitstream/handle/10665/162441/9789241549127_eng.pdf;jsessionid=EF14F4BD2211FBE0B024AA1688B9E0A1?sequence=1

# data[].attributes.body
Artemisinin-based combination therapy (ACT)

artemether + lumefantrine

artesunate + amodiaquine

artesunate + mefloquine

dyhydroartemisinin + piperaquine

artesunate + sulfadoxine-pyrimethamine

# data[].attributes.body
Atovaquone/Proguanil

Chloroquine

Doxycycline

Mefloquine

Primaquine

# data[].attributes.body
Mosquito nets

Indoor Spraying

# data[].attributes.body
10-15 days after mosquito bite

Starts as fever, headache, chills

Fatigue, altered mental status, paleness, respiratory distress

# data[].attributes.headline
     Almost 1/2 of the worlds population!

# data[].attributes.subject
     Almost 1/2 of the worlds population!

# data[].attributes.body
91 countries with active transmission in 2016

Most at risk:

Children >5 years old

Pregnant women

Patients with HIV/AIDS

Travelers

# data[].attributes.body
Life threatening protozoal disease

Caused by plasmodium parasite

Carried by the female anopheles mosquito

216 million cases in 2016

445,000 deaths in 2015

90% cases in WHO African Region